Ampio Pharmaceuticals (AMPE) +7% after its Optima treatment for diabetes-related vision problems...

|About: Ampio Pharmaceuticals, Inc. (AMPE)|By:, SA News Editor

Ampio Pharmaceuticals (AMPE) +7% after its Optima treatment for diabetes-related vision problems produced "encouraging" results in phase II testing. Ampio plans to discuss the next trial with the FDA at the end of the month. (PR)